FAM160B1

Across TCGA pan-cancer cohorts, FAM160B1 mass-spec protein is linked to patient survival in 5 of 34 cancer types, making it a survival-associated FAM160B1 data layer compared with 23 for mass-spec protein and 7 for mutation status.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher FAM160B1 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated FAM160B1 expression acts as an unfavorable survival marker, although some lineages such as PDAC and GBM show a favorable association.

COAD, CCRCC, and PDAC are the cancer types where FAM160B1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Tertile	II,III,IV	0.913	1.000	.039	30	view →
CCRCC	OS	Median	IV	0.123	0.785	.009	25	view →
PDAC	DFS	Quartile	II,III,IV	0.995	0.630	.002	10	view →
GBM	OS	Median	All	0.897	0.639	.003	7	view →
LUAD	OS	Median	All	0.965	0.793	.040	1	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

FAM160B1–COAD (DFS)

Open the COAD breakdown →